Teva Slams Eli Lilly's 'Free Ride' On Migraine IP As Trial Opens

By Brian Dowling · October 19, 2022, 2:57 PM EDT

Teva Pharmaceuticals kicked off its migraine drug patent infringement trial against Eli Lilly and Co. on Wednesday, telling a Boston federal jury that the rival shouldn't be allowed to "free ride"...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company

Case Number

Court

Massachusetts

Nature of Suit

Patent

Date Filed

September 27, 2018

Recent Articles By Brian

May 16, 2025
Surgical Center Operator Inks $15M Deal Over Data Breach
May 15, 2025
Spinal Implant Co. CEO Pleads Guilty Ahead Of Kickback Trial
May 01, 2025
Mammogram Provider Facing Wave Of Data Breach Suits
April 17, 2025
Ex-Harvard Morgue Manager Takes Plea Over Stolen Remains
April 15, 2025
Pa. Man To Plead Guilty In Harvard Body Parts Theft Case
April 14, 2025
Quinn Emanuel, King & Spalding Rep Harvard In Trump Letter
March 19, 2025
UMass Medical Execs To Face Retaliation Claim In Vax Dispute
March 18, 2025
Feds Reject 'Absurd' Defense In Harvard Body Parts Case
March 10, 2025
Ex-Magellan CEO Pleads Guilty Over Faulty Lead Tests
March 05, 2025
Trump's NIH Cost-Cutting Measure Blocked By Judge